The investigation of mithochondrialpermeability transition pore (mptp) inthe development of myocardial andvascular contractility disfunctions
A.V. Dmitrieva, V.F. Sagach, A. Yu. Boguslavsky
A.A. Bogomoletz Institute of Physiology National Academy ofSciences of Ukraine, Kiev
Abstract
In experiments on the isolated myocardial and vascular
preparations the role of the mithochondrial permiability tran-
sition pore (mPTP) in the development of reperfusion injury
was investigated. Co-perfusion of the previously activated
myocardial trabecula (МТ) and arterial rings (AR) by solution
collected during the first 5 min of isolated heart reperfusion,
caused a sharp and significant decrease of tonic tension of both
isolated preparations. Besides the significant inhibition of the
МТ and АR reactions after electrical stimulation, modulation
of AR reaction by the influence of MT is also registered. The
solution collected at first minutes of heart reperfusion, pre-
serve a dilation property within 24 hours of storage at room
temperature. Preliminary perfusion of МТ and АR with
methylen blue (МB, 10-4 М/l) or the addition to the solution
dithiothreitol (DTT, 2.10-5 М/l) and diethyl maleate (DEM,
2.10-5 М/l) resulted in an almost complete inhibition of this
dilatation influence on the isolated preparations. The data
received testify that the solution comprise a NO-containing
substance, possible nitrosoglutation. Pre-incubation (2 min)
МТ in a solution with mPTP activator phenylarsine oxide
(PAO, 10-5 М/l) and subsequent reperfusion with a control
solution resulted in deep and irreversible decrease of tonic
tension and inhibition of contractility of both isolated prepa-
rations. The received data are qualitatively similar to results
described above. Our data and results received in additional
experiments on isolated mitochondria allow us to assert that
solution flowing from the ischemized heart contains the stable
mitochondrial factor (SMF) with a significant dilatation prop-
erty. An addition of МB and DEM in the reperfusion solution
abrogated its dilation influence. Co-perfusion (10 min) of the
injured МТ and АR by the solution with nitrosoglutation (10-
5 М/l) restored normal contractility of the isolated prepara-
tions and modulation of the AR reaction by the influence of
MT. It once again confirms the presence of an NO-containing
substance in the SMF content. Thus, the mPTP activation
plays the key role in the development of myocardial reperfusion
injury and results in release of SMF, which can be the basic
agent of paracrine regulation of myocardial contractility,
coronary and peripheral vessels tone.
References
- Жукова А. В. Модулюючий вплив ендотеліальногорелаксуючого фактора на реактивність міокарда таартеріальних судинних смужок // Фізіол. журн. –1999. – 45, № 1–2. – С. 64–72.
- Сагач В.Ф., Вавілова Г.Л., Струтинська Н.А., Ако-пова О.В. Вплив індукторів та інгібіторів мітохонд-ріальної пори на її утворення та на вивільненнянеіндентифікованого мітохондріального фактора //Там само. – 2003. – 49, №1. – С. 3–12.
- Сагач В.Ф., Дмитрієва А.В., Шиманська Т.В.,Надточій С.М. Фактор, який вивільнюється під часреперфузії ішемізованого серця, дослідженнявпливу на міокард, коронарні та периферичнісудини // Там само. – 2002. – 48, №1. – С. 3–8.
- Сагач В.Ф., Шиманська Т.В., Надточій С.М. Фактор,який вивільнюється під час реперфузії ішемізова-ного серця, може бути маркером відкриттямітохондріальної пори // Там само. – 2003. – 49,№ 4. – С. 7–13.
- Bolli R., Bhatti Z.A., Tang X.L., Qiu Y.M. Evidencethat late preconditioning against myocardial stanningin conscious rabbits triggered by the generation of ni-tric oxide // Circulat.Res. – 1997. – 81, № 1. – P.42–52.
- Borutaite V., Jekabsone A., Morkuniene R., BrownG.C. Inhibition of mitochondrial permiability transionprevent mitochondrial dysfunction, cytochrom c releaseand apoptosis inuced by heart ischemia // J.Mol.Cell.Cardiol. – 2003. – 35.–P. 357–366.
- Borutaite V., Morkuniene R., Brown G.C. Nitric oxidedonors, nitrosothiols and mitochondrial respirationinhibitors induce caspase activation by different mecha-nisms // FEBS Lett. – 2000. – 467. – P. 155–159.
- Crompton M. The mitochondrial permeability transi-tion pore and its role in cell death // Biochem. J. –1999. – 341. – P. 233–249.
- 9. Crompton M., Andreeva L. On the involvement of amitochondrial pore in reperfusion injury // Bas. Res.Cardiol. – 1993. – 88. – P. 513–523.
- 10. Flaherty J., Weisfeldt M. Reperfusion injury // FreeRadic. Biol. And Med. – 1988. – 5, №5–6. – Р. 409–419.
- Jekabsone A., Dapkunas Z., Brown G.C., Borutaite V.S-Nitrosothiol-induced rapid cytochrom c release,caspase activation and mitochondrial permiabilitytransition in perfused heart // Biochem. Pharmacol. –2003. – 66. – Р. 1513–1519.
- Korge P., Goldhaber J.I., Weiss J.N. Phenylarsine ox-ide induced mitochondrial permeability transition,hypercontracture, and cardiac cell death // Amer. J.Physiol. – 2001. – 280. – P. H2203–H2213.
- Lefer A.M. Significance of lipid mediators in shockstates // Circulat. Shock. – 1989. – 27. – P. 3–12.
- Mayer B., Pfeiffer S., Schrammel A. et al. A new pathway ofnitric oxide/cyclic GMP signaling involving S-nitrisogluta-tione // J. Biol. Chem. – 1998. – 273, №6. – P. 3264–3270.
- Murphy A. Mitochondria in human disease // The Bio-chemist. – 2000. – 4. – P. 29–34.
- Sastre J., Pallardo F.V., Vina J. Mitochondrial oxida-tive stress play a key role in aging and apoptosis //Life. – 2000. – 49. – P. 427–435.
- Stamler J.S., Jaraki O., Osborn J. et al. Nitric oxidecirculates in mammalian plasma primary as an S–nitrosoadduct of serum albumin // Proc. Natl. Acad USA. –1992. – 89. – 7674–7677.
- Stefen M., Sarkela T.M., Gubina A.A. et al. Methabo-lism of nitrosoglutatione in intact mitоchondria //Biochem. J. – 2001. – 356. – P. 395–402.
|